Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial

Detalles Bibliográficos
Autores principales: Huhn, S, Weinhold, N, Nickel, J, Pritsch, M, Hielscher, T, Hummel, M, Bertsch, U, Huegle-Doerr, B, Vogel, M, Angermund, R, Hänel, M, Salwender, H J, Weisel, K, Dürig, J, Görner, M, Kirchner, H, Peter, N, Graeven, U, Lordick, F, Hoffmann, M, Reimer, P, Blau, I W, Jauch, A, Dembowsky, K, Möhler, T, Wuchter, P, Goldschmidt, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543255/
https://www.ncbi.nlm.nih.gov/pubmed/28504661
http://dx.doi.org/10.1038/bmt.2017.91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543255/
https://www.ncbi.nlm.nih.gov/pubmed/28504661
http://dx.doi.org/10.1038/bmt.2017.91

Ejemplares similares